The pharmaceutical industry is under significant pressure to innovate, reduce costs and remain competitive. New forms of therapy, digital technologies, regulatory requirements and global supply chains require leaders who are convincing strategically, scientifically and operationally.
Wirz & Partners supports pharmaceutical companies, life sciences organisations and investors in filling key positions at board, C-level and senior management level. We understand the demands of an industry in which excellence, safety, efficiency and success are closely connected.
The pharmaceutical industry is developing at high speed. Innovative medicines, personalised therapies, digital health solutions, AI-supported research, new manufacturing processes and increasing requirements around sustainability and security of supply are fundamentally changing the industry.
At the same time, pharmaceutical companies are facing growing pressure: development cycles are long and costly, regulatory requirements are complex, margins are under scrutiny, and healthcare systems around the world are increasingly cost-oriented. Companies must translate innovation more quickly into effective, approved and economically viable solutions.
These changes have a direct impact on the requirements placed on executives. What is needed are personalities who combine scientific understanding with regulatory precision, entrepreneurial thinking and international leadership experience.
Switzerland has been a globally relevant location for pharmaceuticals and life sciences for decades. Basel is one of the world’s leading pharmaceutical clusters and is home to Roche, Novartis and many other life sciences companies, research institutions and specialised service providers.
Zurich/Zug, the Lake Geneva region, Lausanne, Neuchâtel and Ticino also play important roles. Depending on the region, the focus lies on headquarters functions, research, production, digital health, innovation close to MedTech, supply chain, clinical development or industrial excellence.
For pharmaceutical companies, this creates major opportunities: access to highly qualified talent, proximity to universities and hospitals, international networks, regulatory expertise and an innovation-friendly environment. At the same time, this density intensifies competition for experienced leaders.
Especially for key positions, the relevant candidate market is often international, discreet and difficult to access. The best leaders are rarely actively looking. They must be identified in a targeted way, approached professionally and won over with a compelling perspective.
Pharmaceutical companies are complex organisations. Research, development, production, approval, quality, sales, market access and medical affairs must be closely aligned. A wrong appointment in a key role can delay development programmes, increase regulatory risks or weaken commercial opportunities.
In the pharmaceutical industry, key appointments are business-critical. The right leader can accelerate approval processes, reduce production risks, improve market opportunities, stabilise teams and successfully implement transformation.
Our executive search approach is aligned with these requirements. We analyse the strategic starting point, define the relevant competency profile together with our clients, and identify candidates who fit the role professionally, culturally and personally.
In doing so, we do not focus only on job titles or experience, but on demonstrable impact: Who has led complex programmes? Who understands international regulation? Who can work with medical, commercial and operational stakeholders? Who fits the culture and the company’s next stage of development?
Our goal is not the quick placement of a CV. Our goal is a sustainable appointment that creates real added value for your company.
Wirz & Partners understands the pharmaceutical industry as an interplay of science, regulation, production, market and leadership. That is exactly where we come in.